sub study for NIH FDS COVID-19 Workshop

Request for Approval under the “Conference, Meeting, Workshop, Registration and Challenges Generic Clearance (OD)”

(OMB#: 0925-0740, Expiration Date 09/30/2025)

TITLE OF INFORMATION COLLECTION: NIH/FDA COVID-19 Virtual Workshop (hosted by NCI and NIAID)

PURPOSE: The goal of the COVID-19 Workshop on December 15, 2022 is to bring together researchers working on COVID-19 in the NIH and FDA communities in order to accelerate COVID-19 research by sharing data, knowledge, and research resources, as well as helping train NIH and FDA trainees to communicate important advances in medical science. The agenda for the workshop primarily includes scientific sessions on topics related to COVID-19, including diagnostics, therapeutics, vaccines, clinical studies, basic science studies, virology, epidemiology, public health, and emerging technologies. The COVID-19 Workshop also provides a critical training opportunity for NIH/FDA fellows, postbacs, and graduate students by presenting their research to a diverse audience of NIH/FDA scientists. Trainees, research staff, and investigators will have the chance to present their work either as a longer talk (merit-based) or during one of several flash talk sessions. Senior scientists will also serve as session chairs and discussion leaders. This workshop directly advances the missions of the NIH and the FDA to promote human health and address significant health priorities of understanding, preventing, and treating COVID-19. We estimate there will be 600 respondents registering for this event with only 100 abstracts for an average of 5 minutes per response time. Registration for this workshop will open on September 30, 2022.

DESCRIPTION OF RESPONDENTS: Tenured and tenure-track PIs, Staff Scientists, Staff Clinicians, research fellows, clinical fellows, postdoctoral fellows, postbacs, graduate students, and research staff at the NIH and FDA.

TYPE OF COLLECTION: (Check all that apply)

[ X ] Abstract [ ] Application

[ ] Challenges and Competition

[ X ] Registration Form [ ] Other: ______________________

CERTIFICATION:

I certify the following to be true:

1. The collection is voluntary.

2. The collection is a low burden for respondents and a low cost for the Federal Government.

3. The collection is non-controversial and does not raise issues of concern to other federal agencies.

Name: Pamela L. Schwartzberg, MD PhD

To assist review, please provide answers to the following question:

Personally Identifiable Information:

1. Is personally identifiable information (PII) collected? [X] Yes [ ] No

2. If Yes, is the information that will be collected included in records subject to the Privacy Act of 1974? [X] Yes [ ] No

Gifts or Payments:

Is an incentive (e.g., money or reimbursement of expenses, token of appreciation) provided to participants? [ ] Yes [X] No

Amount: _________

The explanation for incentive: (include a number of visits, etc.)

ESTIMATED BURDEN HOURS and COSTS

Category of Respondent	No. of Respondents	No. of Responses per Respondent	Time per Response (in hours)	Total Burden Hours
Individuals	600	1	5/60	50
Totals		600		50

COST TO RESPONDENT

Category of Respondent	Total Burden Hours	Hourly Wage Rate*	Total Burden Cost
Individuals	50	$ 49.44	$ 2,472.00
Total			$ 2,472.0

*Source of the mean Hourly Wage Rate is provided by the Bureau of Labor Statistics, Occupation title “Medical Scientists” 19-1040, https://www.bls.gov/oes/2021/May/oes_nat.htm#19-1040.

FEDERAL COST: The estimated annual cost to the Federal government is $1,388.66.

Staff	Grade/Step	Salary**	% of Effort	Fringe (if applicable)	Total Cost to Gov’t
Federal Oversight
Program Director	14/5	$138,866	1%		$1,388.66
Contractor Cost					$0
Travel					$0
Other Cost					$0
Total					$1,388.66

**The salary in the table above is cited from https://www.opm.gov/policy-data-oversight/pay-leave/salaries-wages/salary-tables/22Tables/html/DCB.aspx

The selection of your targeted respondents

1. Do you have a customer list or something similar that defines the universe of potential respondents, and do you have a sampling plan for selecting from this universe? [X] Yes [ ] No

If the answer is yes, please provide a description of both below (or attach the sampling plan). If the answer is no, please explain how you plan to identify your potential group of respondents and how you will select them.

This meeting is advertised through the COVID-19 Scientific interest group, the Immunology Interest Group, and the Virology Interest Group listserves, as well as other NIH/NCI and NCI Frederick listserves that serve the NIH and FDA communities, as well as individual labs and COVID-19 interest group steering committee members from the NIH and FDA.

Administration of the Instrument

How will you collect the information? (Check all that apply)

[X] Web-based or other forms of Social Media

[ ] Telephone

[ ] In-person

[ ] Mail

[ ] Survey Form

[ ] Chart Abstraction

[ ] Other, Explain

Will interviewers, facilitators, or research coordinators be used? [ ] Yes [X] No

Please ensure that all instruments, instructions, and scripts are submitted with the request.

6